Renal cell carcinomas produce IL-6, IL-10, IL-11, and TGF-β1 in primary cultures and modulate T lymphocyte blast transformation

Journal of Interferon and Cytokine Research

Volumn 17, Issue 2, 1997, Pages 95-102

  Knoefel, Brigitte ^a,d   Nuske, Karin ^a   Steiner, Thomas ^a   Junker, Kerstin ^a   Kosmehl, Hartwig ^a   Rebstock, Katrin ^b   Reinhold, Dirk ^c   Junker, Udo ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b 'Agricola Krankenhaus' Thueringenklinik   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d Institute of Clinical Immunology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; GROWTH REGULATION; HUMAN; HUMAN TISSUE; IMMUNOREGULATION; KIDNEY CARCINOMA; LYMPHOCYTE TRANSFORMATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; T LYMPHOBLAST; TUMOR IMMUNITY;

EID: 0031038884     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1997.17.95     Document Type: Article

References (27)

1. YOSHIDA, M., OHYASHIKI, K., OCHI, H., GIBAS, Z., PONTES, J.E., PROUT, G.R., HUBEN, R., and SANDBERG, A.A. (1986). Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma. Cancer Res. 46, 2139-2147.
2. LARSSON, P. (1994). Cell proliferation in renal cell carcinoma. Scand. J. Urol. Nephrol. 165 (Suppl.), 1-48.
3. HAYAKAWA, M., HATANO, T., OGAWA, T., GAKIYA, M., OGURA, H., and OSAWA, A. (1994). Treatment of advanced renal cell carcinoma using regional arterial administration of lymphokine-activated killer cells in combination with low doses of rIL-2. Urol. Int. 53, 117-124.
4. KLETSCHER, B.A., QIAN, J., BOSTWICK, D.G., ANDREWS, P.E., and ZINCKE, H. (1995). Prospective analysis of multifocality in renal cell carcinoma: Influence of histological pattern, grade, number, size, volume and deoxyribonucleic acid ploidy. J. Urol. 153, 904-906.
5. MUKAMEL, E., KONICHEZKY, M., ENGELSTEIN, D., and SERVADIO, C. (1988). Incidental small renal cell tumors accompanying clinically overt renal cell carcinoma. J. Urol. 140, 22-28.
6. MOURAD, W.A., NESTOK, B.R., SALEH, G.Y., SOLEZ, K., POWER, R.F., and JEWELL, L.D. (1994). Dysplastic tubular epithelium in "normal" kidney associated with renal cell carcinoma. Am. J. Surg. Pathol. 18, 1117-1124.
7. TAKENAWA, J., KANAKO, Y., FUKYOMOTO, M., FUKATSU, A., HIRANO, T., FUKUYAMA, H., NAKAYAMA, F., FUJITA, J, and YOSHIDA, O. (1991). Enhanced expression of IL-6 in primary human renal cell carcinoma. J. Natl. Cancer Inst. 3, 1668-1672.
8. PHILLIPS, A.O., STEADMAN, R., TOPLEY, N., and WILLIAMS, J.D. (1995). Elevated D-glucose concentrations modulate TGF-beta 1 synthesis by human cultured renal proximal tubular cells: The permissive role of platelet-derived growth factor. Am. J. Pathol. 147, 362-374.
9. MIKI, S., IWANO, M., MIKI, Y., YAMAMOTO, M., TANG, B., YOKOKAVA, K., SONODA, T., HIRANO, T., and KISHIMOTO, T. (1989). Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinoma. FEBS Lett. 250, 607-610.
10. BARNARD, J.A., LYONS, R.M., and MOSES, H.M. (1990). The cell biology of transforming growth factor beta. Biochem. Biophys. Acta 1032, 79-87.
11. REINHOLD, D., BANK, U., BÜHLING, F., LENDECKEL, U., ULMER, A.J., FLAD, H.D., and ANSORGE, S. (1994). Transforming growth factor-β1 (TGF-β1) inhibits DNA synthesis of PWM-stimulated PBMC via suppression of IL-2 and IL-6 production. Cytokine 6, 382-388.
12. REINHOLD, D., BANK, U., BÜHLING, F., LENDECKEL, U., and ANSORGE, A. (1995). Transforming growth factor β1 inhibits interleukin-10 mRNA expression and production in pokeweed mitogen-stimulated peripheral blood mononuclear cells and T cells. J. Interferon Cytokine Res. 15, 685-690.
13. TAGA, K., MOSTOWSKI, H., and TOSATO, G. (1993). Human interleukin-10 can directly inhibit T-cell growth. Blood 81, 2964-2971.
14. CERWENKA, A., BEVEC, D., MAJDIC, O., KNAPP, W., and HOLTER, W. (1994). TGF-beta 1 is a potent inducer of human effector T cells. J. Immunol. 153, 4367-4377.
15. MOORE, K.W., O'GARRA, A., DE WAAL MALEFYT, R., DE VIEIRA, P., and MOSMANN, T.R. (1993). Interleukin 11. Annu. Rev. Immunol. 11, 165-190.
16. HOROWITZ, M.C., and LEVY, J.B. (1995). The LIF/IL-6 subfamily of cytokines induce protein phosphorylation and signal transduction by nonreceptor tyrosine kinases in human and murine osteoblasts. Calcif. Tissue Int. 56(Suppl. 1), S32-S34.
17. YIN, T., and YANG, Y.C. (1993). Protein tyrosine phosphorylation and activation of primary response genes by interleukin 11 in B9-TY1 cells. Cell Growth Diff. 4, 603-609.
18. WOODROOFE, C., MULLER, W., and RUTHER, U. (1992). Long-term consequences of interleukin-6 overexpression in transgenic mice. DNA Cell Biol. 11, 587-592.
19. NISHIMOTO, N., OGATA, A., SHIMA, Y., TANI, Y., OGAWA, H., NAKAGAWA, M., SUGIYAMA, H., YOSHIZAKI, K., and KISHIMOTO, T. (1994). Oncostatin-M, leukemia inhibitory factor, and interleukin-6 induce the proliferation of human plasmacytoma cells via the common signal transducer, GP130. J. Exp. Med. 179, 1343-1347.
20. HOUSSIAU, F., and VAN SNICK, J. (1992). IL6 and the T-cell response. Res. Immunol. 143, 740-743.
21. FISCHER, P., BAUM, R.P., TAUBER, M., BOECKMANN, W., STÖRKEL, S., WEIER, S., and SCHERBERICH, J.E. (1992). Novel monoclonal antibody 138H11. against human gamma-glutamyl-transferase: Classification, histogenesis and immunoscintigraphy of renal tumors. In: Basic and Clinical Research on Renal Cell Carcinoma. Berlin, Heidelberg: Springer-Verlag, pp. 148-155.
22. ABRAHAMS, J.S., RONCAROLO, M.-G., YSSEL, H., ANDERSSON, U., GLEICH, G.J., and SILVER, J.E. (1992). Strategies of anti-cytokine monoclonal antibodydevelopment: Immunoassay of IL-10 and IL-5 in clinical samples. Immunol. Rev. 127, 5-24.
23. DANIELPOUR, D. (1993). Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor beta-1. J. Immunol. Methods 158, 17-25.
24. ECKSTEIN, R., STROHSCHEER, I., BEYER, J., LENZ, K., WITTMANN, G., ZINGSEM, J., WEISBACH, V., HUHN, D., and MEMPEL, W. (1991). Versuche zur Entwicklung eines standardisierten Testsystems immunologischer Reaktivität. Transfusionsmedizin/Infusionstherapie Beitr. Infusionther. (Basel) 30, 332-337.
25. BLAY, J.Y., SCHEMANN, S., and FAVROT, M.C. (1994). Local production of interleukin-6 by renal adenocarcinoma in vivo. J. Natl. Cancer Inst. 86, 238.
26. FILGUEIRA, L., ZUBER, M., MERLO, A., CAETANO, V., SCHULTZ, E., HARDER, F., SPAGNOLI, G.C., and HEBERER, M. (1993). Cytokine gene transcription in renal cell carcinoma. Br. J. Surg. 80, 1322-1325.
27. GOGUSEV, J., AUGUSTI, M., CHRETIEN, Y., and DROZ, D. (1993). Interleukin-6 and TNF alpha production in human renal cell carcinoma. Kidney Int. 44, 585-592.